Search

pSivida

Article Timeline

Past Employees

NamePositionYear StartedYear Ended
Brian Leedman Vice President, Investor Relations20042014
Roger Aston Director20062007
Gavin Rezos Chief Executive Officer20002006

ECM Deals

DateCompanyTransaction TypeTotal Value
14/01/16pSividaPublic offer$25.5m>>

Biography

pSivida is a leading provider of miniaturized, sustained-release drug delivery products and is continuing the evolution of these systems.
Formerly an ASX listed company, pSivida's intellectual property portfolio consists of over 150 issued patents in countries including the U.S., Europe, Japan, China and Australia. pSivida, a NASDAQ listed company, is developing products designed to revolutionize treatments, with a primary focus in ophthalmology.
Biography last updated 26 Oct 2015

BNiQ Disclaimer